{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001795091","name":"OS Therapies Inc","summary":"OS Therapies Incorporated is a clinical-stage biopharmaceutical company focused on developing treatments for Osteosarcoma and other solid tumors. Its lead product, OST-HER2, is a Listeria monocytogenes-based cancer immunotherapy targeting HER2-expressing tumors. The company completed a Phase IIb trial showing 75% two-year overall survival versus 40% historical control. It also owns the OST-tADC platform, a next-generation antibody-drug conjugate technology using pH-sensitive silicone linkers.","people":[],"products":[{"name":"OST-HER2 (OST31-164)","type":"platform","description":"Genetically engineered attenuated Listeria monocytogenes-based immunotherapy expressing HER2 peptides, targeting Osteosarcoma and potentially other HER2-expressing solid tumors."},{"name":"OST-tADC","type":"platform","description":"Next-generation tunable antibody-drug conjugate platform using pH-sensitive silicone linkers (SiLinkers) for targeted cytotoxic payload delivery to solid tumors."}],"partnerships":[{"partner_name":"BlinkBio, Inc.","partnership_type":"licensing","description":"OS Therapies in-licensed the OST-tADC tunable antibody-drug conjugate technology from BlinkBio.","start_date":null},{"partner_name":"George Clinical, Inc.","partnership_type":"development","description":"Contract research organization that conducted the Phase IIb clinical trial of OST-HER2.","start_date":null},{"partner_name":"Syngene International Limited","partnership_type":"development","description":"Integrated CRO based in Bangalore, India, conducting discovery work for the OST-tADC lead program.","start_date":null}],"affiliations":[],"origin":{"leaf":"db22ec86bb52d4def3285b0b12bd7284123f9cd806d6644b2058caf0d88b7b81","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"d172b8d42511d5cd81c4bc12fc03340b04005489a85addc8198cd3319fb17ad0","parent":"d18d318fc21d38f9c4408751124326a93f72a41be8487763b05bc7f5f5bd7b07","source":"0001213900-26-036629","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":313,"hourly_limit":500,"remaining":187,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}